differences between dafrex and daflon and their uses

differences between dafrex and daflon and their uses in treating vascular weakness such as hemorrhoids and varicose veins, and their effectiveness in stopping bleeding by increasing the resistance of blood vessels and protecting them from bleeding. This is due to their active ingredients that support blood circulation by increasing the elasticity of veins, which improves blood flow. Therefore, they are used to treat circulatory problems. We will learn about the difference between the two medications, all the relevant information, and the recommended dosages.

Dafrex Ingredients

It consists of the following active ingredients:

• Hesperidin, a substance belonging to a group of plant compounds known as bioflavonoids, which are anti-inflammatory and antioxidant compounds.
• Diosmin, a chemical found naturally in some plants, such as citrus fruits, supports blood circulation and is used to treat circulatory disorders.

Daflon Ingredients

It contains the active ingredients diosmin and hesperidin, which are effective in increasing the strength of blood vessels and thus increasing the contraction force of veins. This reduces the amount of blood accumulating in the veins and lowers blood pressure in the veins.

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 23 August 2025